The first outbreak reported in the U.S. of the highly drug-resistant bacteria strain has been linked to eye drops.
NY Mets veteran catcher Thomas Nido is nearing a return from the 10-day injured list due to a vision issue.
A recent public safety notification warns that eye drops being marketed as disease treatments have not been proven safe or effective.
An Indian pharmaceutical company is at the center of three eyecare product contamination warnings this month.
The maker of EzriCare Artificial Tears has announced a recall of the over-the-counter product.
We’ve been told our entire lives not to rub our eyes. Yet we can't seem to help ourselves. It is time to stop.
Glaucoma is one of the leading causes of irreversible blindness in the U.S. and around the globe.
OneSight EssilorLuxottica Foundation, LensCrafters, and local non-profit Frontline Response hosted the five-day charitable clinic.
The global eye health company enters lucrative market with Project Watson to support dogs' eyes, ears and overall well-being.
Omlonti was developed jointly by Santen and UBE.
With the help of her eyecare team and theater professor, her eye trauma became her new lease on life.
The transaction will support iSTAR Medical's development and commercial efforts for MINIject.
Diopsys became a wholly owned subsidiary of LumiThera, Inc.
Over 1 million EVO lenses have been implanted by doctors outside the U.S.
Wellspring "will now seek a licensee who will complete development and commercialize its newly acquired innovative platform."
Including the ongoing increase in Glaucoma and why some suffers choose to forgo treatment.
Social media initiative includes donation to Prevent Blindness’ sight-saving fund.
The approval "marks a milestone for patients and eye care professionals," says the CEO of Oyster Point Pharma.
This global initiative is aimed to bring attention to the growing epidemic of myopia in children across the world.
The legislation was signed into law on Jan. 1.
Advertisement